These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34117675)

  • 21. Resolution of organ fibrosis.
    Jun JI; Lau LF
    J Clin Invest; 2018 Jan; 128(1):97-107. PubMed ID: 29293097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte and macrophage derived myofibroblasts: Is it fate? A review of the current evidence.
    Vierhout M; Ayoub A; Naiel S; Yazdanshenas P; Revill SD; Reihani A; Dvorkin-Gheva A; Shi W; Ask K
    Wound Repair Regen; 2021 Jul; 29(4):548-562. PubMed ID: 34107123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast and myofibroblast activation in normal tissue repair and fibrosis.
    Younesi FS; Miller AE; Barker TH; Rossi FMV; Hinz B
    Nat Rev Mol Cell Biol; 2024 Aug; 25(8):617-638. PubMed ID: 38589640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The plasticity of fibroblasts: A forgotten player in the aging process.
    Salminen A
    Ageing Res Rev; 2023 Aug; 89():101995. PubMed ID: 37391015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations.
    Schafer MJ; Haak AJ; Tschumperlin DJ; LeBrasseur NK
    Curr Rheumatol Rep; 2018 Jan; 20(1):3. PubMed ID: 29374361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host responses in tissue repair and fibrosis.
    Duffield JS; Lupher M; Thannickal VJ; Wynn TA
    Annu Rev Pathol; 2013 Jan; 8():241-76. PubMed ID: 23092186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hard problem: Mechanotransduction perpetuates the myofibroblast phenotype in scleroderma fibrosis.
    Leask A
    Wound Repair Regen; 2021 Jul; 29(4):582-587. PubMed ID: 33410577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In wound repair vimentin mediates the transition of mesenchymal leader cells to a myofibroblast phenotype.
    Walker JL; Bleaken BM; Romisher AR; Alnwibit AA; Menko AS
    Mol Biol Cell; 2018 Jul; 29(13):1555-1570. PubMed ID: 29718762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Senotherapeutics: Targeting senescence in idiopathic pulmonary fibrosis.
    Merkt W; Bueno M; Mora AL; Lagares D
    Semin Cell Dev Biol; 2020 May; 101():104-110. PubMed ID: 31879264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contraction.
    Sarrazy V; Koehler A; Chow ML; Zimina E; Li CX; Kato H; Caldarone CA; Hinz B
    Cardiovasc Res; 2014 Jun; 102(3):407-17. PubMed ID: 24639195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?
    Walraven M; Akershoek JJ; Beelen RH; Ulrich MM
    Arch Dermatol Res; 2017 Mar; 309(2):111-121. PubMed ID: 28004279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective.
    Gerarduzzi C; Di Battista JA
    Inflamm Res; 2017 Jun; 66(6):451-465. PubMed ID: 28040859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of myofibroblasts in wound healing.
    Hinz B
    Curr Res Transl Med; 2016; 64(4):171-177. PubMed ID: 27939455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods for Studying Myofibroblast Apoptotic Pathways.
    Zhou Y; Lagares D
    Methods Mol Biol; 2021; 2299():123-137. PubMed ID: 34028739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment.
    Leask A
    Fibrogenesis Tissue Repair; 2010 May; 3():8. PubMed ID: 20507556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 50 Years of Myofibroblasts: How the Myofibroblast Concept Evolved.
    Gabbiani G
    Methods Mol Biol; 2021; 2299():1-5. PubMed ID: 34028731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myofibroblasts.
    Hinz B
    Exp Eye Res; 2016 Jan; 142():56-70. PubMed ID: 26192991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling.
    Borkham-Kamphorst E; Schaffrath C; Van de Leur E; Haas U; Tihaa L; Meurer SK; Nevzorova YA; Liedtke C; Weiskirchen R
    Biochim Biophys Acta; 2014 May; 1843(5):902-14. PubMed ID: 24487063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular senescence controls fibrosis in wound healing.
    Jun JI; Lau LF
    Aging (Albany NY); 2010 Sep; 2(9):627-31. PubMed ID: 20930261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin induces differential expression of cytoprotective enzymes but similar apoptotic responses in fibroblasts and myofibroblasts.
    Lundvig DMS; Pennings SWC; Brouwer KM; Mtaya-Mlangwa M; Mugonzibwa EA; Kuijpers-Jagtman AM; Von den Hoff JW; Wagener FADTG
    Exp Cell Res; 2015 Jan; 330(2):429-441. PubMed ID: 25447314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.